Salud financiera de hoja de balance de CSPC Pharmaceutical Group
Salud financiera controles de criterios 5/6
CSPC Pharmaceutical Group tiene un patrimonio de accionistas total de CN¥36.5B y una deuda total de CN¥388.9M, lo que sitúa su ratio deuda-patrimonio en 1.1%. Sus activos y pasivos totales son CN¥47.9B y CN¥11.4B respectivamente. El BAIT de CSPC Pharmaceutical Group es de CN¥6.4B, por lo que su ratio de cobertura de intereses es de -29.4. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥10.8B.
Información clave
1.1%
Ratio deuda-patrimonio
CN¥388.87m
Deuda
| Ratio de cobertura de intereses | -29.4x |
| Efectivo | CN¥10.82b |
| Patrimonio | CN¥36.47b |
| Total pasivo | CN¥11.42b |
| Activos totales | CN¥47.90b |
Actualizaciones recientes sobre salud financiera
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20Recent updates
Is CSPC Pharmaceutical Group Limited (HKG:1093) Trading At A 48% Discount?
Nov 15Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16Earnings Not Telling The Story For CSPC Pharmaceutical Group Limited (HKG:1093) After Shares Rise 26%
Sep 30CSPC Pharmaceutical Group Limited (HKG:1093) Investors Are Less Pessimistic Than Expected
Aug 08Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think
May 29CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14
May 21CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14
Apr 29There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price
Apr 22CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14
Apr 01CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate
Jan 22Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
Jan 04Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?
Oct 22Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price
Jul 09Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 01CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11
Apr 04CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price
Mar 12Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥26.5B) de 1093 superan a sus pasivos a corto plazo (CN¥10.4B).
Pasivo a largo plazo: Los activos a corto plazo de 1093 (CN¥26.5B) superan a sus pasivos a largo plazo (CN¥988.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 1093 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 1093 ha crecido de 0.3% a 1.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1093 está bien cubierta por el flujo de caja operativo (1101.6%).
Cobertura de intereses: 1093 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.